Antiproton induced DNA damage: proton like in flight, carbon-ion like near rest
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Biological validation of new radiotherapy modalities is essential to understand their therapeutic potential. Antiprotons have been proposed for cancer therapy due to enhanced dose deposition provided by antiproton-nucleon annihilation. We assessed cellular DNA damage and relative biological effectiveness (RBE) of a clinically relevant antiproton beam. Despite a modest LET (~19 keV/μm), antiproton spread out Bragg peak (SOBP) irradiation caused significant residual γ-H2AX foci compared to X-ray, proton and antiproton plateau irradiation. RBE of ~1.48 in the SOBP and ~1 in the plateau were measured and used for a qualitative effective dose curve comparison with proton and carbon-ions. Foci in the antiproton SOBP were larger and more structured compared to X-rays, protons and carbon-ions. This is likely due to overlapping particle tracks near the annihilation vertex, creating spatially correlated DNA lesions. No biological effects were observed at 28-42 mm away from the primary beam suggesting minimal risk from long-range secondary particles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Agostinelli, S., Allison, J., Amako, K., Apostolakis, J., Araujo, H., Arce, P., Asai, M., Axen, D., Banerjee, S., Barrand, G., et al. (2003) · Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment · doi:10.1016/s0168-9002(03)01368-8 · Cited by 25,106
Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 15,104
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438
Intensity-modulated radiation therapy, protons, and the risk of second cancers
Hall, E. J. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.027 · Cited by 1,110
Formation of Clustered DNA Damage after High-LET Irradiation: A Review
HADA, M., & GEORGAKILAS, A. G. (2008) · Journal of Radiation Research · doi:10.1269/jrr.07123 · Cited by 449
Elsässer, T., Weyrather, W. K., Friedrich, T., Durante, M., Iancu, G., Krämer, M., Kragl, G., Brons, S., Winter, M., Weber, K.-J., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.05.014 · Cited by 351
A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy
Lomax, A. J., Bortfeld, T., Goitein, G., Debus, J., Dykstra, C., Tercier, P.-A., Coucke, P. A., & Mirimanoff, R. O. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00036-5 · Cited by 245
Track structure analysis of ultrasoft X-rays compared to high- and low-LET radiations
Goodhead, D. T., & Nikjoo, H. (1989) · International Journal of Radiation Biology · doi:10.1080/09553008914550571 · Cited by 223
Costes, S. V., Chiolo, I., Pluth, J. M., Barcellos-Hoff, M. H., & Jakob, B. (2010) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2009.12.006 · Cited by 206
Ion beam radiobiology and cancer: Time to update ourselves
Fokas, E., Kraft, G., An, H., & Engenhart‐Cabillic, R. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.07.005 · Cited by 170
Research works printed but not linked: 1
- Abramoff, M. D., Magelhaes, P. J. & Ram, S. J. Image processing with Image J. Biophotonics International 11, 36–42 (2004).
Cited by
Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia
Elming, P., Sørensen, B., Oei, A., Franken, N., Crezee, J., Overgaard, J., & Horsman, M. (2019) · Cancers · doi:10.3390/cancers11010060 · Cited by 205
A systematic review on the usage of averaged LET in radiation biology for particle therapy
Kalholm, F., Grzanka, L., Tranéus, E., & Bassler, N. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.04.007 · Cited by 138
Self-citationAlotaibi, M., Sharma, K., Saleh, T., Povirk, L. F., Hendrickson, E. A., & Gewirtz, D. A. (2016) · Radiation Research · doi:10.1667/rr14202.1 · Cited by 90
“As for DNA damage and senescence it has been established that ionizing radiation induces DNA damage foci, the majority of which are transient and disappear within hours after treatment (20, 21).”
Applied nuclear physics at the new high-energy particle accelerator facilities
Durante, M., Golubev, A., Park, W.-Y., & Trautmann, C. (2019) · Physics Reports · doi:10.1016/j.physrep.2019.01.004 · Cited by 72
Carante, M. P., Aimè, C., Cajiao, J. J. T., & Ballarini, F. (2018) · Physics in Medicine & Biology · doi:10.1088/1361-6560/aab45f · Cited by 52
“The lines are simulation outcomes, whereas the points are experimental data taken from Hamada et al (2006) (76.3 keV µm−1 and 108.0 keV µm−1) and Kavanagh et al (2013) (48.8 keV µm−1 and 147.6 keV µm−1).”
MethodInfluentialChromosome aberrations and cell death by ionizing radiation: evolution of a biophysical model
Ballarini, F., & Carante, M. P. (2016) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2016.06.009 · Cited by 45
Current and future accelerator technologies for charged particle therapy
Owen, H. L., Lomax, A., & Jolly, S. W. (2015) · Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment · doi:10.1016/j.nima.2015.08.038 · Cited by 44
“Whilst other more exotic ions and species such as pions [133] and antiprotons [134, 135, 136] were examined in the past, carbon remains the favoured ion species in use today and thus developments focus there.”
BackgroundModeling radiation-induced cell death: role of different levels of DNA damage clustering
Carante, M. P., Altieri, S., Bortolussi, S., Postuma, I., Protti, N., & Ballarini, F. (2015) · Radiation and Environmental Biophysics · doi:10.1007/s00411-015-0601-x · Cited by 48
“A very similar relationship was adopted by Kreth et al. (2007) applying their spherical chromatin domain model to chromosome aberration induction in gamma-irradiated human lymphocytes, which led to good agreement with dicentric data but overestimated the yield of centric rings.”
BackgroundMethodTechnologies for delivery of proton and ion beams for radiotherapy
Owen, H. L., Holder, D., Alonso, J., & Mackay, R. I. (2014) · International Journal of Modern Physics A · doi:10.1142/s0217751x14410024 · Cited by 36
“Recent studies confirm such an RBE enhancement, but at present there is disagreement about the acceptability of the longer-range halo dose.(44,45,46) Held out as a great hope for treatment of glioblastoma, boron neutroncapture therapy (BNCT) is a combined technique in which epithermal neutrons (from a suitable reactor…”
BackgroundComparing Photon and Charged Particle Therapy Using DNA Damage Biomarkers
Ray, S., Cekanaviciute, E., Paulino‐Lima, I. G., Sørensen, B. S., & Costes, S. V. (2018) · International Journal of Particle Therapy · doi:10.14338/ijpt-18-00018.1 · Cited by 33
“The residual number of DNA damage after 24 to 26 hours, which is presumably reflecting unrepaired DSBs, has been shown to be LET dependent in more studies, also in the clinical relevant LET range for proton irradiation [36, 38, 75, 76] (Figure 3).”
BackgroundDi, C., Han, L., Zhang, H., Xu, S., Mao, A., Sun, C., Liu, Y., Si, J., Li, H., Zhou, X. H., et al. (2015) · Scientific Reports · doi:10.1038/srep16020 · Cited by 23
Sato, T., Matsuya, Y., & Hamada, N. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.05.010 · Cited by 24
Ramos, R. L., Embriaco, A., Carante, M. P., Ferrari, A., Sala, P., Vercesi, V., & Ballarini, F. (2022) · Journal of Radiological Protection · doi:10.1088/1361-6498/ac6991 · Cited by 17
“6 keV μm−1 [31, 32] (panel (a)) or He ions at 16.”
Girard, N., Lhuissier, E., Aury‐Landas, J., Cauvard, O., Lenté, M., Boittin, M., Baugé, C., & Boumédiene, K. (2020) · Journal of bone oncology · doi:10.1016/j.jbo.2020.100283 · Cited by 17
Neutron activation of gadolinium for ion therapy: a Monte Carlo study of charged particle beams
Delinder, K. W. V., Khan, R. F. H., & Gräfe, J. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-70429-9 · Cited by 10
Hyland, W. B., McMahon, S. J., Butterworth, K. T., Cole, A., King, R. B., Redmond, K. M., Prise, K. M., Hounsell, A. R., & McGarry, C. K. (2014) · British Journal of Radiology · doi:10.1259/bjr.20130781 · Cited by 9
“Taken from the literature, repair half-times of 16, 90 and 130min were used for DU-145, H460 and AGO-1552b cells, respectively.(21,27,28) The calculated values were incorporated into the linear quadratic model to calculate the corresponding surviving fractions.”
MethodSelf-citationden Heuvel, F. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110333 · Cited by 9
Шматов, М. Л. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/20/n383 · Cited by 5
“…and, therefore, will damage practically only tumor cells (Gray and Kalogeropoulos 1984, Sullivan 1985, Holzscheiter et al 2004a, 2004b, 2006, Hall 2006, Bassler and Holzscheiter 2009, Fahimian et al 2009, Bassler et al 2010, Kavanagh et al 2010, 2013, Paganetti et al 2010, Bittner et al 2014).”
BackgroundDifferential cross sections for ionization of atomic hydrogen by antiprotons
Bondarev, A. I., Kozhedub, Y. S., Tupitsyn, I. I., Шабаев, В. М., Plunien, G., & Stöhlker, T. (2019) · Hyperfine Interactions · doi:10.1007/s10751-019-1562-2 · Cited by 3
Kovo, Y. (2015)
Shin, H., Jung, J., Kim, M.-S., Kim, S.-M., Choi, Y., Yoon, D., & Suh, T. S. (2018) · Japanese Journal of Applied Physics · doi:10.7567/jjap.57.060305
Overview of antiproton affinities for functional groups relevant in particle‐beam cancer therapy
Stegeby, H. (2018) · Cancer Reports · doi:10.1002/cnr2.1128
Rich, T. A., Pan, D., Chordia, M. D., Keppel, C., Beylin, D., Stepanov, P., Jung, M., Pang, D., Grindrod, S. C., & Dritschilo, A. (2021) · International Journal of Particle Therapy · doi:10.14338/ijpt-d-20-00036.1
“An overlapping goal is to address the concept of using a therapeutic proton beam’s nuclear atomic effects to harness an increased and selective cytotoxicity effect in cancer cells [15, 16].”
BackgroundDifferential cross sections for ionization of hydrogen-like atoms by proton and antiproton impact
Nassar, T. E. I., & Tantawi, R. S. (2022) · The European Physical Journal D · doi:10.1140/epjd/s10053-021-00324-z
Particle Neutron Gamma-X Detection (PNGXD)
Delinder, K. W. V. (2023) · doi:10.32920/24192354
Particle Neutron Gamma-X Detection (PNGXD)
Delinder, K. W. V. (2023) · doi:10.32920/24192354.v1
Metadata
- Authors
- Kavanagh, J. N., Currell, F. J., Timson, D. J., Savage, K. I., Richard, D. J., McMahon, S. J., Hartley, O., Cirrone, G. A. P., Romano, F., Prise, K. M., Bassler, N., Holzscheiter, M. H., & Schettino, G.
- Affiliations
- Queen's University Belfast (GB)
- Queensland University of Technology (AU)
- University of Geneva (CH)
- Istituto Nazionale di Fisica Nucleare, Sezione di Catania (IT)
- Aarhus University (DK)
- University of New Mexico (US)
- Corresponding author
- Kavanagh, J. N.
- ORCID
- Venue
- Scientific Reports
- Published
- 2013-05-03
- Volume
- 3
- Issue
- 1
- Pages
- 1770-1770
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3642660
- OpenAlex
- W2112352029
- Cited by
- 26
- References
- 43
- Citations by year
- 2023: 2 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 4 · 2016: 2 · 2015: 5 · 2014: 3
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- Research Portal (Queen's University Belfast) (acceptedVersion, cc-by-nc-nd)
- QUT ePrints (Queensland University of Technology) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- University of Brighton Repository (University of Brighton) (submittedVersion)
- GSI Repository (German Federal Government) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- GSI Repository (German Federal Government)
- Funders
- European Commission (262010, 2007–2013, FP7 2007-2013, FP7/2007)
- Engineering and Physical Sciences Research Council (EP/H017844/1, EP/I017550/1)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Keywords
- antiprotons, DNA damage, relative biological effectiveness, spread-out Bragg peak, antiproton-nucleon annihilation, γH2AX foci, carbon ion radiotherapy, proton therapy, LET, secondary particles, effective dose
- MeSH terms
- Carbon, Cell Survival, Cells, Cultured, DNA Damage, Humans, Ions, Protons, Radiotherapy, Radiotherapy Dosage, Relative Biological Effectiveness, X-Rays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.